乳腺癌患者先行乳房切除术后未即刻重建:无填充物光子放疗与含填充物电子线放疗的比较
本研究回顾性比较807例乳腺癌乳房切除术后未即刻重建患者,583例接受含填充物高适形电子线放疗(PMERT),224例接受无填充物高适形光子放疗(PMPhRT),均50 Gy/25次。中位随访64个月,PMPhRT组局部区域复发风险显著高于PMERT组(亚分布HR 3.62,95%CI 1.07-12.3,P=.04),总生存无显著差异。
要点
- PMPhRT组局部区域复发风险显著高于PMERT组:亚分布HR 3.62(95%CI 1.07-12.3,P=.04)。
- 5年局部区域复发率PMERT组0.53%(95%CI 0-1.12%),PMPhRT组2.52%(95%CI 0.05%-4.6%)。
- 两组总生存无显著差异:HR 1.2(95%CI 0.67-2.13,P=.54)。
核心结论
- 与含填充物高适形电子线放疗(PMERT)相比,无填充物高适形光子放疗(PMPhRT)组观察到更高的局部复发风险。
- 作者认为需要前瞻性随机试验来确认这些发现。
研究设计与样本
- 研究为在本院2个院区接受乳房切除术后放疗(PMRT)且未即刻重建的乳腺癌女性,均于2012年前治疗,采用两种不同技术。
- 共807例患者,其中583例接受PMERT,224例接受PMPhRT。
- 所有患者接受50 Gy分25次照射,既往接受新辅助化疗者被排除。
主要发现
- 中位随访64个月。
- PMERT组中位年龄52.7岁(范围26-91岁),三阴性占6.9%,HER2阳性占16.3%,多发病灶占58.6%。
- PMPhRT组中位年龄56.4岁(范围28-89岁),三阴性占8.5%,HER2阳性占12.9%,多发病灶占55.8%。
- 淋巴结受累在PMERT组和PMPhRT组分别为66%和72.8%(P=.07)。
- 两组总生存无显著差异(HR 1.2;95%CI 0.67-2.13;P=.54)。
关键数值与推荐
- 采用Fine-Gray法估计的局部区域复发风险PMPhRT组显著高于PMERT组(亚分布HR 3.62;95%CI 1.07-12.3;P=.04)。
- 5年局部区域复发率PMERT组为0.53%(95%CI 0-1.12%),PMPhRT组为2.52%(95%CI 0.05%-4.6%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为需要前瞻性随机试验来确认这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate locoregional control and outcome after mastectomy in patients treated with postmastectomy highly conformal electron radiation therapy (PMERT) with bolus compared with patients treated by highly conformal photon radiation therapy (PMPhRT) without bolus in the adjuvant setting of nonmetastatic breast cancer. METHODS AND MATERIALS: We studied women undergoing PMRT without immediate reconstruction for breast cancer before 2012 in 2 sites of our hospital using 2 different techniques. All patients received 50 Gy in 25 fractions. Patients previously treated by neoadjuvant chemotherapy were excluded. RESULTS: Among the 807 patients, 583 received PMERT and 224 received PMPhRT. The median follow-up was 64 months. Patients in the PMERT group had a median age of 52.7 years (range, 26-91 years), 6.9% were triple-negative, 16.3% were HER2-positive, and 58.6% had multifocal lesions. Patients in the PMPhRT group had a median age of 56.4 years (28-89), 8.5% were triple negative, 12.9% were HER2-positive, and 55.8% had multifocal lesions. Lymph node involvement was observed in 66% and 72.8% of cases (P = .07) treated with PMERT and PMPhRT, respectively. No significant difference in overall survival was observed between the 2 groups (hazard ratio [HR], 1.2; 95% CI, 0.67-2.13; P = .54). The risk of locoregional recurrence, estimated using the Fine-Gray method, was significantly higher with PMPhRT than with PMERT (subdistribution HR, 3.62; 95% CI, 1.07-12.3; P = .04), corresponding to a 5-year LRR rate of 0.53% (95% CI, 0-1.12%) for PMERT and 2.52% (95% CI, 0.05%-4.6%) for PMPhRT. CONCLUSIONS: A higher risk of local recurrence was observed in the PMPhRT without bolus group compared with the PMERT with bolus group. Prospective randomized trials are needed to confirm these findings.
引用
- Boulle G, Saint-Martin C, De La Lande B, et al. Photons Without Bolus Versus Electrons With Bolus After Upfront Mastectomy Without Immediate Reconstruction in Breast Cancer Patients. Int J Radiat Oncol Biol Phys. 2019. PMID: 30926576. doi:10.1016/j.ijrobp.2019.03.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。